API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
USP
0
JP
0
Other Listed Suppliers
0
0
82
PharmaCompass offers a list of Benzarone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Benzarone manufacturer or Benzarone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Benzarone manufacturer or Benzarone supplier.
PharmaCompass also assists you with knowing the Benzarone API Price utilized in the formulation of products. Benzarone API Price is not always fixed or binding as the Benzarone Price is obtained through a variety of data sources. The Benzarone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1477-19-6 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1477-19-6, including repackagers and relabelers. The FDA regulates 1477-19-6 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1477-19-6 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 1477-19-6 supplier is an individual or a company that provides 1477-19-6 active pharmaceutical ingredient (API) or 1477-19-6 finished formulations upon request. The 1477-19-6 suppliers may include 1477-19-6 API manufacturers, exporters, distributors and traders.
click here to find a list of 1477-19-6 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 1477-19-6 Drug Master File in Japan (1477-19-6 JDMF) empowers 1477-19-6 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 1477-19-6 JDMF during the approval evaluation for pharmaceutical products. At the time of 1477-19-6 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 1477-19-6 suppliers with JDMF on PharmaCompass.
A 1477-19-6 written confirmation (1477-19-6 WC) is an official document issued by a regulatory agency to a 1477-19-6 manufacturer, verifying that the manufacturing facility of a 1477-19-6 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 1477-19-6 APIs or 1477-19-6 finished pharmaceutical products to another nation, regulatory agencies frequently require a 1477-19-6 WC (written confirmation) as part of the regulatory process.
click here to find a list of 1477-19-6 suppliers with Written Confirmation (WC) on PharmaCompass.
1477-19-6 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1477-19-6 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1477-19-6 GMP manufacturer or 1477-19-6 GMP API supplier for your needs.
A 1477-19-6 CoA (Certificate of Analysis) is a formal document that attests to 1477-19-6's compliance with 1477-19-6 specifications and serves as a tool for batch-level quality control.
1477-19-6 CoA mostly includes findings from lab analyses of a specific batch. For each 1477-19-6 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1477-19-6 may be tested according to a variety of international standards, such as European Pharmacopoeia (1477-19-6 EP), 1477-19-6 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1477-19-6 USP).